Mark R. Bowles

Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by Human Liver Carboxylesterase

Laurent P. Rivory, Mark R. Bowles, Jacques Robert et al. · Biochemical Pharmacology · 1996 · 231 citations

Medicine, Pharmacokinetics, Pharmacology +14

Evaluation of equilibrium constants for antigen-antibody interactions by solid-phase immunoassay: The binding of paraquat to its elicited mouse monoclonal antibody

Philip J. Hogg, S. Claiborne Johnston, Mark R. Bowles et al. · Molecular Immunology · 1987 · 76 citations

Pharmacy, Immunology, Monoclonal Antibodies +12

Studies of Protein Interactions by Biosensor Technology: An Alternative Approach to the Analysis of Sensorgrams Deviating from Pseudo-First-Order Kinetic Behavior

Mark R. Bowles, Damien Hall, Susan M. Pond et al. · Analytical Biochemistry · 1997 · 39 citations

Natural Sciences, Biochemistry, Biophysics +17

Large scale production and purification of paraquat and desipramine monoclonal antibodies and their fab fragments

Mark R. Bowles, S. Claiborne Johnston, Deric D. Schoof et al. · International Journal of Immunopharmacology · 1988 · 38 citations

Pharmacy, Biochemistry, Biotechnology +16

Human Papillomavirus Type 6b Virus-Like Particles Are Able To Activate the Ras-MAP Kinase Pathway and Induce Cell Proliferation

Elizabeth Payne, Mark R. Bowles, Alistair Don et al. · Journal of Virology · 2001 · 34 citations

Life Sciences, Cell Biology, Molecular Biology +17